Advertisement
Advertisement
DXCM
DexCom, Inc.
72.10
USDSponsored
+0.20
+0.28%
May 22, 16:00 UTC -4
Closed
Pre-Market
72.52
+0.42
+0.58%
DXCM Earnings Reports
Positive Surprise Ratio
DXCM beat 32 of 42 last estimates.
76%
Next Report
Date of Next Report
Jul 28, 2026
Estimate for Q2 26 (Revenue/ EPS)
$1.32B
/$0.62
Implied change from Q1 26 (Revenue/ EPS)
+10.39%
/+10.71%
Implied change from Q2 25 (Revenue/ EPS)
+13.71%
/+29.17%
DexCom, Inc. earnings per share and revenue
On Apr 30, 2026, DXCM reported earnings of 0.56 USD per share (EPS) for Q1 26, beating the estimate of 0.47 USD, resulting in a 17.03% surprise. Revenue reached 1.19 billion, compared to an expected 1.20 billion, with a -0.54% difference. The market reacted with a +3.02% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 23 analysts forecast an EPS of 0.62 USD, with revenue projected to reach 1.32 billion USD, implying an increase of 10.71% EPS, and increase of 10.39% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Alpha Tau Medical Ltd. Ordinary Shares
Report Date
May 18, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.26
Surprise
-106.35%
Microbot Medical, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.05
Surprise
+36.06%
Solana Company Class A Common Stock (DE)
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.48
Actual
-$1.03
Surprise
-110.38%
DarioHealth Corp. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$1.50
Actual
-$1.25
Surprise
+17.20%
Precision Optics Corporation, Inc. Common Stock
Report Date
May 13, 2026 For Q3 26
Estimate
-Actual
-$0.01
Surprise
-
SiNtx Technologies, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.67
Actual
-$0.70
Surprise
-3.98%
PAVmed Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.71
Actual
-$4.42
Surprise
-519.05%
Tenon Medical, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.31
Actual
-$0.28
Surprise
+6.78%
NexGel, Inc Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.11
Surprise
-54.06%
ENDRA Life Sciences Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$1.25
Actual
-$1.80
Surprise
-43.47%
FAQ
What were DexCom, Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, DexCom, Inc. reported EPS of $0.56, beating estimates by 17.03%, and revenue of $1.19B, -0.54% below expectations.
How did the market react to DexCom, Inc.'s Q1 2026 earnings?
The stock price moved up 3.02%, changed from $59.55 before the earnings release to $61.35 the day after.
When is DexCom, Inc. expected to report next?
The next earning report is scheduled for Jul 28, 2026.
What are the forecasts for DexCom, Inc.'s next earnings report?
Based on 23
analysts, DexCom, Inc. is expected to report EPS of $0.62 and revenue of $1.32B for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement